
Extended INDIGO and FIREFLY-1 results presented at SNO 2026 put seizure burden during vorasidenib therapy and time off tovorafenib in pediatric low-grade glioma into focus.
Renvela is a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
Medication Pearl of the Day: Renvela (Sevelamer Carbonate)
Indication: Renvela is a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
Insights:
Source:






